GlassScriptPhysician profile
Jonathan L Masel
NPI 1013900414
$9,775.52
in general payments reported to CMS, 2019-2025
48 companies · $1,829 in 2025
The $1,829 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,104 · 2020: $810 · 2021: $1,110 · 2022: $790 · 2023: $3,201 · 2024: $932 · 2025: $1,829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,721 · Travel and Lodging: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,720.62 |
| Travel and Lodging | $1,241.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,358.14 | 2021-2025 | Nanoknife |
| Antares Pharma, INC. | $1,243.41 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $773.36 | 2019-2025 | |
| Procept Biorobotics Corporation | $476.38 | 2020-2025 | Aquabeam System, Aquabeam Robotic System |
| Janssen Biotech, INC. | $428.25 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Verity Pharmaceuticals INC. | $380.32 | 2021-2025 | Tlando, Trelstar |
| Rochester Medical Corporation | $353.83 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $344.35 | 2019-2022 | |
| Boston Scientific Corporation | $237.21 | 2019-2025 | Axonics, Lithovue Elite, Rezum Generator |
| Becton, Dickinson and Company | $226.03 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Astellas Pharma US INC | $209.04 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $207.62 | 2023-2025 | |
| Karl Storz Endoscopy-America | $180.00 | 2019 | |
| Axonics, INC. | $170.21 | 2020-2024 | Axonics |
| Allergan, INC. | $167.70 | 2019-2021 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $153.83 | 2021-2024 | Lithostat, Uribel Tabs, Uribel |
| Halozyme INC | $127.86 | 2023 | |
| Tolmar, INC. | $124.18 | 2023-2025 | Eligard, Jatenzo |
| Endo USA, INC. | $110.79 | 2024-2025 | Xiaflex |
| Intuitive Surgical, INC. | $102.75 | 2023-2024 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $95.71 | 2020 | |
| Myovant Sciences INC. | $87.98 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $87.51 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $80.65 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $79.72 | 2019-2023 | Bard Urinary Drainage Bag |
| Teleflex LLC | $77.54 | 2021-2022 | |
| Bioprotect Medical, INC. | $76.26 | 2025 | Bioprotect Balloon Implant System |
| Progenics Pharmaceuticals, INC. | $75.71 | 2022-2025 | |
| Accord Healthcare, INC. | $69.95 | 2024-2025 | |
| Olympus America INC. | $65.61 | 2023-2024 | Itind System |
| Laborie Medical Technologies Corp. | $62.53 | 2022-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Biotissue Holdings INC. | $61.19 | 2023-2025 | |
| Dornier Medtech America, INC | $54.47 | 2019 | |
| Clarus Therapeutics INC. | $42.60 | 2021 | |
| Coloplast Corp | $42.05 | 2024 | |
| Urogen Pharma, INC. | $41.74 | 2021-2023 | Jelmyto |
| Acerus Pharmaceuticals Corporation | $30.74 | 2022 | |
| Calyxo, INC. | $30.02 | 2025 | Cvac Aspiration System |
| Dendreon Pharmaceuticals LLC | $29.48 | 2025 | Provenge |
| Sumitomo Pharma America, INC. | $27.50 | 2025 | Orgovyx |
| Merck Sharp & Dohme LLC | $26.84 | 2023 | Lynparza, Keytruda |
| Telix Pharmaceuticals | $25.29 | 2023 | Illuccix |
| Foundation Medicine, INC. | $23.60 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $23.14 | 2022 | |
| Agiliti Surgical, INC. | $22.86 | 2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Astrazeneca Pharmaceuticals LP | $22.55 | 2022 | |
| Blue Earth Diagnostics | $22.07 | 2024 | |
| Dentsply Ih INC. | $14.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Masel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.